Reimbursement and Companion Diagnostics

The Reimbursement and Companion Diagnostics stream at the Next Generation Dx Summit explores how innovative diagnostics are shaping the future of precision medicine, from predictive biomarkers and AI-enabled tools to market access and reimbursement strategy. Participants will examine advances in digital and computational pathology, biomarker strategies, and emerging indications, alongside evolving legislative, coding, and payer considerations. This stream offers a forum for diagnostic developers, biopharma leaders, regulators, and payers to share perspectives and collaboratively develop solutions. Discussions will focus on regulatory impacts, clinical validation, coverage pathways, and early strategies for adoption and commercialization.

August 24-25

Coverage and Reimbursement for Diagnostic Innovation

August 25-26

AI, Digital, and Emerging Technologies in Companion Diagnostics

Keynote and Featured Presentations:

Policy, Assessments, and DEX—Navigating Coverage and Reimbursement for Diagnostic Innovation
Gabriel Bien-Willner, MD, PhD, Medical Director, MolDx, Palmetto GBA

Computational Pathology and AI-Enabled Precision Medicine
Alexander Baras, MD, PhD, Leon Troper Professorship in Computational Pathology, Associate Professor of Pathology, Urology, and Oncology, Director of Computational Pathology & Informatics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine